Vivos Therapeutics, Inc. (VVOS)Healthcare | Medical Devices | Littleton, United States | NasdaqCM
0.97 USD
-0.12
(-10.633%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 1.03 +0.06 (5.739%) ⇧ (April 17, 2026, 7:38 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:40 p.m. EDT
VVOS offers no safety margin: the stock is trading at highsilicon-poor levels relative to the 200-day average (-5.7% buffer) amid severe liquidity constraints (Current Ratio 0.24), negative free cash flow, and a statistically significant short-term model predicting -16.58% over 45 days. The recent price volatility and deep discounting (-15% in the last 48 hours) reflect growing uncertainty rather than a pivot to sustainability. Without a capital raise or a near-proven catalyst, this remains a high-risk speculative hold rather than a value opportunity. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.272340 |
| AutoARIMA | 0.325466 |
| AutoETS | 0.325474 |
| MSTL | 0.341050 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 48% |
| H-stat | 5.24 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.516 |
| Excess Kurtosis | -0.84 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 1.698 |
| Market Cap | 13,136,719 |
| Forward P/E | -2.78 |
| Profit Margins | -121.37% |
| Website | https://www.vivos.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.55727273 |
| Address1 | 7,921 Southpark Plaza |
| Address2 | Suite 210 |
| All Time High | 360.25 |
| All Time Low | 0.96 |
| Ask | 1.01 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 586,950 |
| Average Daily Volume3 Month | 195,070 |
| Average Volume | 195,070 |
| Average Volume10Days | 586,950 |
| Bid | 0.9634 |
| Bid Size | 2 |
| Book Value | 0.306 |
| City | Littleton |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.9741 |
| Current Ratio | 0.243 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.1 |
| Day Low | 0.9601 |
| Display Name | Vivos Therapeutics |
| Earnings Call Timestamp End | 1,776,286,800 |
| Earnings Call Timestamp Start | 1,776,286,800 |
| Earnings Timestamp | 1,776,283,200 |
| Earnings Timestamp End | 1,778,788,800 |
| Earnings Timestamp Start | 1,778,788,800 |
| Ebitda | -18,585,000 |
| Ebitda Margins | -1.06547 |
| Enterprise To Ebitda | -1.321 |
| Enterprise To Revenue | 1.407 |
| Enterprise Value | 24,549,718 |
| Eps Current Year | -1.25 |
| Eps Forward | -0.35 |
| Eps Trailing Twelve Months | -2.07 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.3576 |
| Fifty Day Average Change | -0.38349998 |
| Fifty Day Average Change Percent | -0.2824838 |
| Fifty Two Week Change Percent | -55.727272 |
| Fifty Two Week High | 7.95 |
| Fifty Two Week High Change | -6.9758997 |
| Fifty Two Week High Change Percent | -0.8774717 |
| Fifty Two Week Low | 0.96 |
| Fifty Two Week Low Change | 0.014100015 |
| Fifty Two Week Low Change Percent | 0.014687516 |
| Fifty Two Week Range | 0.96 - 7.95 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,607,697,000,000 |
| Float Shares | 12,650,818 |
| Forward Eps | -0.35 |
| Forward P E | -2.7831428 |
| Free Cashflow | -10,112,750 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.60437 |
| Gross Profits | 10,542,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.26471 |
| Held Percent Institutions | 0.0798 |
| Implied Shares Outstanding | 13,486,007 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,020-12-11 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,698,364,800 |
| Last Split Factor | 1:25 |
| Long Business Summary | Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado. |
| Long Name | Vivos Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 13,136,719 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_529678289 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -21,170,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 13,293,156 |
| Number Of Analyst Opinions | 3 |
| Open | 1.1 |
| Operating Cashflow | -15,263,000 |
| Operating Margins | -1.66893 |
| Payout Ratio | 0.0 |
| Phone | 844 672 4357 |
| Post Market Change | 0.055899978 |
| Post Market Change Percent | 5.7386284 |
| Post Market Price | 1.03 |
| Post Market Time | 1,776,469,103 |
| Previous Close | 1.09 |
| Price Eps Current Year | -0.77928 |
| Price Hint | 4 |
| Price To Book | 3.1833334 |
| Price To Sales Trailing12 Months | 0.7531227 |
| Profit Margins | -1.21367 |
| Quick Ratio | 0.2 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.1159 |
| Regular Market Change Percent | -10.633 |
| Regular Market Day High | 1.1 |
| Regular Market Day Low | 0.9601 |
| Regular Market Day Range | 0.9601 - 1.1 |
| Regular Market Open | 1.1 |
| Regular Market Previous Close | 1.09 |
| Regular Market Price | 0.9741 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 666,431 |
| Return On Assets | -0.61498 |
| Return On Equity | -6.63023 |
| Revenue Growth | 0.034 |
| Revenue Per Share | 1.698 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 13,486,006 |
| Shares Percent Shares Out | 0.026700001 |
| Shares Short | 316,118 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 478,895 |
| Short Name | Vivos Therapeutics, Inc. |
| Short Percent Of Float | 0.029000001 |
| Short Ratio | 2.7 |
| Source Interval | 15 |
| State | CO |
| Symbol | VVOS |
| Target High Price | 7.0 |
| Target Low Price | 1.75 |
| Target Mean Price | 4.75 |
| Target Median Price | 5.5 |
| Total Cash | 2,029,000 |
| Total Cash Per Share | 0.15 |
| Total Debt | 13,502,000 |
| Total Revenue | 17,443,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.07 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.785725 |
| Two Hundred Day Average Change | -1.8116251 |
| Two Hundred Day Average Change Percent | -0.65032446 |
| Type Disp | Equity |
| Volume | 666,431 |
| Website | https://www.vivos.com |
| Zip | 80,120 |